Intramural delivery of a specific tyrosine kinase inhibitor with biodegradable stent suppresses the restenotic changes of the coronary artery in pigs in vivo
- 1 September 1998
- journal article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 32 (3), 780-786
- https://doi.org/10.1016/s0735-1097(98)00312-x
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Tyrosine kinase inhibitor suppresses the (re)stenotic changes of the coronary artery after balloon injury in pigsCardiovascular Research, 1996
- Tyrosine kinase inhibitor suppresses coronary arteriosclerotic changes and vasospastic responses induced by chronic treatment with interleukin-1 beta in pigs in vivo.JCI Insight, 1995
- Biodegradable Stents: The Future of Interventional Cardiology?Journal of Interventional Cardiology, 1995
- Tyrosine-kinase-dependent signaling pathwaysTrends in Cardiovascular Medicine, 1994
- Methods and devices for local drug delivery in coronary and peripheral arteriesTrends in Cardiovascular Medicine, 1993
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- Implantable devices in the coronary artery from metal to genesTrends in Cardiovascular Medicine, 1991
- Signal transduction by receptors with tyrosine kinase activityCell, 1990
- Specific inhibitors of tyrosine-specific protein kinase, synthetic 4-hydroxycinnamamide derivativesBiochemical and Biophysical Research Communications, 1987
- Chemotactic responses of fibroblasts to tropoelastin and elastin-derived peptides.JCI Insight, 1982